StoneX Group’s Accelerate Diagnostics AXDX Stock Holding History
Bought
Maintained
Sold
Other funds holding AXDX
GAM
BC
OIM
CC
CI
TWA
StoneX Group's AXDX Position: Q3 2023 in Review
StoneX Group sold out of Accelerate Diagnostics (AXDX) in Q3 2023, closing a stake of 1,194 shares — an estimated $9.67K sold.
StoneX Group first reported a position in AXDX in Q2 2017 and held it in 23 quarters. The position peaked at $322K in Q2 2017. 38 funds tracked by Wall St. Rank hold AXDX as of Q3 2023.
- StoneX Group reported no remaining Accelerate Diagnostics position as of Q3 2023 after selling out during the quarter.
- StoneX Group sold 1,194 Accelerate Diagnostics shares in Q3 2023, an estimated $9.67K.
- StoneX Group first reported a position in Accelerate Diagnostics in Q2 2017 and held it in 23 quarters.
- StoneX Group's Accelerate Diagnostics position peaked at $322K in Q2 2017.
- 38 funds tracked by Wall St. Rank held Accelerate Diagnostics as of Q3 2023.
Based on StoneX Group's 13F filing for Q3 2023, filed 15 Nov 2023.